학술논문
Hypercoagulability in ICU Patients With Coronavirus Disease 2019 With Respiratory Failure Results in Increased Prevalence of Venous Thromboembolic Disease.
Document Type
Journal Article
Author
Source
Subject
*COVID-19
*RESPIRATORY insufficiency
*
Language
ISSN
0012-3692
Abstract
The relatively low number of patients assessed does not afford the opportunity to be confident in excluding that there may be a small but significant link to any of these other factors for VTE in patients with COVID-19. The impact of our findings on our practice has been to order ultrasound screening in patients with COVID-19 in our ICUs, and to treat those with positive test results with full-dose IV UFH. To the Editor: Many studies indicate that severe coronavirus disease 2019 (COVID-19) infection is associated with a hypercoagulable state, as evidenced by pathologic findings from lung autopsies.[1] Procoagulant antiphospholipid antibodies have also been reported in patients with COVID-19.[2] We sought to determine the prevalence of DVT in patients with COVID-19 and ARDS within our ICUs. [Extracted from the article]